Obesity, obstructive sleep apnoea and metabolic syndrome
Tóm tắt
OSA is increasingly recognized as a major health problem in developed countries. Obesity is the most common risk factor in OSA and hence, the prevalence of OSA is undoubtedly rising given the epidemic of obesity. Recent data also suggest that OSA is highly associated with the metabolic syndrome, and it is postulated that OSA contributes to cardiometabolic dysfunction, and subsequently vasculopathy.
Current evidence regarding the magnitude of impact on ultimate cardiovascular morbidity or mortality attributable to OSA‐induced metabolic dysregulation is scarce. Given the known pathophysiological triggers of intermittent hypoxia and sleep fragmentation in OSA, the potential mechanisms of OSA–obesity–metabolic syndrome interaction involve sympathetic activation, oxidative stress, inflammation and neurohumoral changes. There is accumulating evidence from human and animal/cell models of intermittent hypoxia to map out these mechanistic pathways.
In spite of support for an independent role of OSA in the contribution towards metabolic dysfunction, a healthy diet and appropriate lifestyle modifications towards better control of metabolic function are equally important as CPAP treatment in the holistic management of OSA.
Từ khóa
Tài liệu tham khảo
CDC, 2005, State‐specific prevalence of obesity among adults—United States, MMWR Morb. Mortal. Wkly. Rep., 55, 985
Obesity:preventing and managing the global epidemic. Report of a WHO consultation.World Health Organ Tech Resp Ser2000;894:i–xii 1–253.
Lam JC, 2010, Sleep and the metabolic syndrome, Indian J. Med. Res., 131, 206
Kissebath AH, 1997, Central obesity: measurement and metabolic effects, Diabet. Rev., 5, 8
McClendon DA, 2010, An analysis of popular weight loss diet types in relation to metabolic syndrome therapeutic guidelines. Review, Medsurg Nurs., 19, 17
Phillips CL, 2009, Changes in regional adiposity and cardiometabolic function following a weight loss program with Sibutramine in obese men with obstructive sleep apnea, J. Clin. Sleep Med., 5, 416, 10.5664/jcsm.27595
Grunstein RR, 1993, Snoring and sleep apnea in men: association with central obesity and hypertension, Int. J. Obes. Relat. Metab. Disord., 17, 533
Lavie L, 2003, Obstructive sleep apnea syndrome‐an oxidative stress disorder, Sleep Med. Rev., 7, 33, 10.1053/smrv.2002.0261
Nieto FJ, 2009, Sleep disordered breathing and metabolic syndrome, WMJ, 108, 263
Tkacova R, 2008, Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea, Med. Sci. Monit., 14, CR438
Papanas N, 2010, Predictors of obstructive sleep apnea in males with metabolic syndrome, Vasc. Health Risk Manag., 6, 281
Wilcox I, 1998, ‘Syndrome Z’: the interaction of sleep apnea, vascular risk factors and heart disease, Thorax, 3, S25
Sharma SK, 2010, Are metabolic syndrome, obstructive sleep apnea, syndrome Z sequential?—a hypothesis, Indian J. Med. Res., 131, 455
Mota PC, 2010, APAP impact on metabolic syndrome in obstructive sleep apnea patients, Sleep Breath.
Furuhashi M, 2008, Adipocyte/macrophage fatty acid‐binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice, J. Clin. Invest., 118, 2640